Foralumab, the only fully human anti-CD3 monoclonal antibody (mAb) currently in clinical development, binds to the T cell receptor and dampens inflammation by modulating T cell function, thereby suppressing effector features in multiple immune cell subsets
PMC 2692399
This review summarizes each step of glutamine metabolism in cancer cells and highlights opportunities for clinical intervention
Store at room temperature in a dry place
doi: 10.3389/fendo.2025.1629488 Received 15 June 2025 Accepted 14 August 2025 Published 10 September 2025 Volume 16 - 2025 Edited by Federico Bertuzzi, Niguarda Ca Granda Hospital, Italy Reviewed by Pratikeswar Panda, Siksha O Anusandhan University, India Basilio Pintaudi, ASST Grande Ospedale Metropolitano Niguarda, Italy Updates Copyright 2025 Castorani, Chiarle, Savastio, Pozzi, Partenope, Pignatiello, Dimarakis, Demichelis, Medina and Rabbone